Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial

Christiane A Geluk, Folkert W. Asselbergs, Hans L. Hillege, Stephan J. L. Bakker, Paul E. de Jong, Felix Zijlstra, Wiek H. van Gilst

European Heart Journal · 2005 · 48 citations · 44 references

DOIFull text

Open access

Abstract

This study supports the use of statins in microalbuminuric subjects with the metabolic syndrome to reduce the incidence of major adverse cardiac events.

References

44